<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03409172</url>
  </required_header>
  <id_info>
    <org_study_id>Aerobic exercise and obesity</org_study_id>
    <nct_id>NCT03409172</nct_id>
  </id_info>
  <brief_title>Inflammatory and Metabolic Outcomes After Obese Woman Performed High Intensity Interval Training</brief_title>
  <official_title>Inflammatory and Metabolic Outcomes in Obese Women After 8 Weeks of High Intensity Interval Training and Moderate Intensity Continuous Training: a Randomized Controlled Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to compare the effects of high intensity interval training
      and moderate intensity continuous training on inflammatory profile and metabolic markers,
      after 8 weeks of intervention trial in obese women.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Actual">January 8, 2018</completion_date>
  <primary_completion_date type="Actual">January 8, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Three-arm parallel, Randomized-controlled study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Outcome Assessors involved in data analysis will not be aware of the arm to which the participants were allocated (single-blinded masking)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Inflammatory profile</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment)</time_frame>
    <description>C-reactive protein (CRP) (mg/dL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inflammatory profile</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment)</time_frame>
    <description>Interleukin 6 (IL-6) (ng/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inflammatory profile</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment)</time_frame>
    <description>Interleukin 10 (IL-10) pg/mL, Interleukin-1B (IL-1B) pg/mL, Tumor Necrosis Factor (TNF)-α (pg/mL), Adiponectin (pg/mL), Monocyte chemoattractant protein 1 (MCP-1) (pg/mL), Leptin (pg/mL)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Composition and Anthropometric profile</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment) ]</time_frame>
    <description>Body weight (kg), Fat free mass (FFM) (kg), fat mass (FM) (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Composition and Anthropometric profile</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment) ]</time_frame>
    <description>Body Mass Index (BMI) (kg/m²)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Composition and Anthropometric profile</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment) ]</time_frame>
    <description>Waist circumference (cm), hip circumference (cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Composition and Anthropometric profile</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment) ]</time_frame>
    <description>Body Adiposity Index (BAI) and Waist-To-Hip Ratio (WHR)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment) ]</time_frame>
    <description>Insulin sensitivity was estimated using homeostasis model assessment index (HOMA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid profile</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment) ]</time_frame>
    <description>Lipid profile was assessed by measuring levels of triglyceride (TG) (mg/dL), total cholesterol (CT) (mg/dL), high-density lipoprotein cholesterol (HDL-C) (mg/dL) and low-density lipoprotein cholesterol (LDL-C) (mg/dL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory Fitness (CRF)</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment) ]</time_frame>
    <description>CRF was assessed by measuring Peak Oxygen uptake (VO2peak) mL/kg/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure (BP)</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment) ]</time_frame>
    <description>Blood Pressure (mmHg) was assessed by measuring rest levels of Systolic blood pressure (SBP) and Diastolic blood pressure (DBP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting Energy Expenditure (REE)</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment) ]</time_frame>
    <description>Resting Energy Expenditure (kcal/day) was measured through indirect calorimetry with an open-circuit ventilated-hood system Substrate oxidation rate was calculated from VO2 (mL/min) and VCO2 (mL/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substrate oxidation rate</measure>
    <time_frame>8 weeks (baseline to 8 week follow-up assessment) ]</time_frame>
    <description>Substrate oxidation rate was calculated from VO2 (mL/min) and VCO2 (mL/min)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Obesity and Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Control group (CTr)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No counseling or nutritional therapy and no exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate intensity continuous training (MICT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Follow-up during a period of 8 weeks of supervised ergometer-based moderate-intensity continuous training based on HRmax (MICT).
MICT:
3 sessions per week
intensity at 65-75% HRmax
time-effort per session: 50 min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Intensity Interval Training (HIIT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Procedures: Follow-up during a period of 8 weeks of supervised ergometer-based high intensity interval training based on HRmax (HIIT).
HIIT:
3 sessions per week
10 bouts of one minute at 90% HRmax interspersed by one minute at 40% HRmax
time-effort per session: 25 min</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CTR</intervention_name>
    <description>no counseling or nutritional therapy and no exercise</description>
    <arm_group_label>Control group (CTr)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MICT</intervention_name>
    <description>no counseling or nutritional therapy. 8 weeks of individualized and supervised ergometer-based moderate continuous intensity training (MICT).</description>
    <arm_group_label>Moderate intensity continuous training (MICT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>HIIT</intervention_name>
    <description>no counseling or nutritional therapy. 8 weeks of individualized and supervised ergometer-based high intensity interval training (HIIT)</description>
    <arm_group_label>High Intensity Interval Training (HIIT)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body Mass Index between (30-40 kg/m²)

          -  age between 25 and 41 years

          -  to be sedentary

        Exclusion Criteria:

          -  type 1 or type 2 diabetes

          -  Hypertension

          -  pregnancy, Lactation

          -  having undergone bariatric surgery

          -  psychological disorders, epilepsy, sever neurological disorders

          -  participation in other moderate, vigorous exercise or nutrition intervention

          -  acute or chronic cardiovascular disease

          -  malignant disease

          -  kidney disease

          -  lung disease

          -  hyperthyroidism or hypothyroidism

          -  smoking any type of cigarette

          -  joint limitations

          -  electronic implants (defibrillator, pacemaker)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>41 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vivian M M SUEN, PhD</last_name>
    <role>Study Director</role>
    <affiliation>fmrp usp</affiliation>
  </overall_official>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2018</study_first_submitted>
  <study_first_submitted_qc>January 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 24, 2018</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Vivian Marques Miguel Suen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>High intensity interval training</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Obesity</keyword>
  <keyword>adipokines</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

